<DOC>
	<DOC>NCT00414960</DOC>
	<brief_summary>To compare the difference of a marker of cellular proliferation in all bronchial biopsy specimens of former smokers stratified by lung cancer risk, collected before and after treatment per patient between the enzastaurin and placebo groups.</brief_summary>
	<brief_title>A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers</brief_title>
	<detailed_description>x</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Sputum atypia participants with normal sputum cytology will be removed from the study) Metaplasia or dysplasia on at least one bronchoscopy specimen History of cigarette smoking &gt;30 Pack Years Quit smoking &gt;1 year prior to study entry Able to undergo bronchoscopy and helical CT scanning of the chest Able to swallow tablets Blood clotting abnormalities Current smoking within the past 1 year Unwillingness to abstain from smoking while enrolled in the clinical trial or are unwillingness to avoid significant second hand smoke exposure Evidence for lung cancer or carcinoma in situ Active cardiovascular disease Current illicit drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Prevention</keyword>
</DOC>